the risk of breast cancer in women taking hormone therapy
August 2003
Even more new information is coming to light about the risk of breast cancer in women taking hormone therapy.
Hormone therapy with conjugated estrogens/ medroxyprogesterone not only increases the risk of breast cancer in older women...but also makes it harder to detect.
Combined estrogen and progestin therapy increases breast tissue density...decreasing a mammogram's ability to detect tumours.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote